Health Care & Life Sciences » Biotechnology | Labgenomics Co. Ltd.

Labgenomics Co. Ltd. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
16,968
23,201
23,590
24,057
24,806
Cost of Goods Sold (COGS) incl. D&A
8,639
11,709
12,413
13,505
14,929
Gross Income
8,329
11,492
11,177
10,553
9,877
SG&A Expense
6,594
8,713
9,946
10,099
11,077
EBIT
1,607
2,616
1,032
220
1,422
Unusual Expense
447
-
11
192
1,516
Non Operating Income/Expense
18
32
125
125
1,085
Interest Expense
143
241
76
90
427
Pretax Income
1,073
2,439
1,173
139
4,303
Income Tax
186
18
453
585
867
Consolidated Net Income
1,260
2,420
1,626
724
3,437
Net Income
1,260
2,420
1,626
724
3,437
Net Income After Extraordinaries
1,260
2,420
1,626
724
3,437
Net Income Available to Common
1,260
2,420
1,626
724
3,437
EPS (Basic)
152.92
331.50
192.00
85.00
404.00
Basic Shares Outstanding
8
7
8
8
9
EPS (Diluted)
152.92
326.79
192.10
85.30
403.70
Diluted Shares Outstanding
8
8
8
8
9
EBITDA
2,994
4,287
2,865
2,503
1,167
Other Operating Expense
128
163
198
233
222
Non-Operating Interest Income
41
89
72
37
126

About Labgenomics Co.

View Profile
Address
6/F, Korea Bio Park B
Seongnam GY 13488
Korea, Republic Of
Employees -
Website http://www.labgenomics.co.kr
Updated 09/14/2018
LabGenomics Co., Ltd. engages in the provision of vitro diagnostic products and services. Its products include sample and bioinformatics analysis, diagnostic checks, and other products. The company was founded on March 29, 2002 and is headquartered in Seongnam, South Korea.